Clinical-stage pharmaceutical company Helus Pharma has announced a collaboration with TARA Mind and Veterans Exploring Treatment Solutions to support clinical trial recruitment for its PARADIGM HLP003 Phase 3 programme for major depressive disorder, while expanding mental health awareness and access within the veteran community, according to Global Newswire.

The partnership aligns with a US Executive Order signed on 18 April 2026 titled "Accelerating Medical Treatments for Serious Mental Illness," which emphasises expanding clinical research participation and advancing innovative treatment approaches for populations, including veterans, who face disproportionately high rates of depression, post-traumatic stress disorder, and suicide.

Eric So, interim chief executive of Helus Pharma, said: "TARA Mind and VETS bring deep experience working with veteran communities. These collaborations will support recruitment efforts for our FDA Breakthrough Therapy-designated HLP003 program while aligning with the broader priorities highlighted in the recent Executive Order to expand research participation and advance innovative treatments for serious mental illness."

Marcus Capone, Chairman and co-founder of TARA Mind, said: "Partnerships like this help strengthen outreach efforts, connect veterans to cutting-edge clinical opportunities, and ensure veterans have the latest resources that support their mental health."

TARA Mind and Veterans Exploring Treatment Solutions will leverage their networks to facilitate veteran engagement and support ongoing recruitment for the PARADIGM programme.

HLP003 is a novel serotonergic agonist in Phase 3 development for the adjunctive treatment of major depressive disorder, having received Breakthrough Therapy Designation from the US Food and Drug Administration. Helus Pharma also has HLP004 in Phase 2 development for generalised anxiety disorder.

The company operates across Canada, the United States, the United Kingdom, and Ireland.

Read the full article for further detail on the Helus Pharma and TARA Mind collaboration.